Kellen Scott bought DMAC
June 1, 2026 · Form 4 insider transaction
Kellen Scott bought 162,000 shares of DiaMedica Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
162,000
Price
$0.00
Total value
N/A
InsiderKellen Scott
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 1, 2026
Filing dateJune 3, 2026
Shares owned after162,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Scheduled to vest with respect to 25% of the shares on the one-year anniversary of the grant date, with the remaining shares scheduled to vest in twelve equivalent quarterly installments.